.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Express Scripts
Novartis
Cerilliant
Accenture
Medtronic
Colorcon
Covington
Mallinckrodt
Cipla

Generated: September 25, 2017

DrugPatentWatch Database Preview

INNOFEM Drug Profile

« Back to Dashboard

Which patents cover Innofem, and what generic Innofem alternatives are available?

Innofem is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in INNOFEM is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.

Summary for Tradename: INNOFEM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list63
Patent Applications: see list9,740
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INNOFEM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
INNOFEM
estradiol
TABLET;ORAL040312-001Nov 19, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
INNOFEM
estradiol
TABLET;ORAL040312-002Nov 19, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
INNOFEM
estradiol
TABLET;ORAL040312-003Nov 19, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Merck
US Department of Justice
Mallinckrodt
Julphar
Cantor Fitzgerald
Citi
Medtronic
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot